The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
This may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...
Leukeran is only available as a brand-name drug. It doesn’t come in a generic version. A generic drug is an exact copy of the active ingredient in a brand-name medication. Generics tend to cost ...
Patients would pay no more than $25 for certain name-brand medications to treat chronic illnesses, including insulin for ...
Veeda Group has rebranded to Veeda Lifesciences, reflecting its evolution into a drug development enterprise. It comprises four strategic units: Clinical Trials, Healthy Volunteer Services, Biopharma ...